Parkinson s Disease · 2015 · 18 citations · 12 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologySleep MedicineParkinson DiseaseParkinsonian DisordersSleep AssessmentSleep DisturbanceSleep-related Movement DisordersSleep-wake DisordersNighttime Symptom ReliefNocturnal Sleep DisturbanceOpen-label TrialsParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapySleep ImpairmentSleep Symptom AssessmentSleepiness In Parkinson Disease
Objectives. This open-label study assessed the efficacy and safety of exclusive night-time administration of transdermal rotigotine in patients with nocturnal and early morning PD symptoms. Methods. Patients with PD and nocturnal and early morning symptoms received transdermal rotigotine patches (2-16 mg/24 h) applied in the evening and removed in the morning for 3 months. Sleep disturbance was assessed with modified Parkinson's Disease Sleep Scale (PDSS-2). Other outcomes included a pain visual analogue scale (VAS) and short-form Parkinson's Disease Questionnaire (PDQ-8) for quality of life. Results. 74 patients completed treatment in this study. At the end of treatment, PDSS-2 total score had improved by mean 10.9 points from baseline (p < 0.001). All three PDSS-2 domain scores (sleep disturbances, nocturnal motor symptoms, and nocturnal symptoms) were also significantly improved by 41%, 56%, and 48%, respectively (p < 0.001). VAS-pain score decreased from 3.2 to 2.3 (p < 0.001). PDQ-8 score decreased from 23.8 to 18.1 (p < 0.001). The most frequently reported adverse events included nausea (9%), anxiety (4%), and dizziness (4%). Conclusions. Night-time administration of transdermal rotigotine is an effective and well tolerated treatment for nocturnal symptoms in patients with PD.
12
Parkinson's disease sleep scale—validation of the revised version PDSS‐2
Claudia Trenkwalder, Ralf Kohnen, Birgit Högl et al. · Movement Disorders · 2011 · 424 citations
Medicine, Neurology, Neuroscience +17
Impulse control disorders in parkinson disease: A multicenter case–control study
Valerie Voon, Mandy Sohr, Anthony E. Lang et al. · Annals of Neurology · 2011 · 396 citations
Medicine, Neurology, Neuroscience +17